VB-201 160mg

DRUG2 trials

Sponsors

Vascular Biogenics Ltd. operating as VBL Therapeutics

Conditions

PsoriasisUlcerative Colitis

Phase 2

A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis

CompletedNCT01837420

Vascular Biogenics Ltd. operating as VBL TherapeuticsPsoriasis

Start: 2012-11-30End: 2014-11-30Updated: 2015-03-27

A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis

CompletedNCT01839214

Vascular Biogenics Ltd. operating as VBL TherapeuticsUlcerative Colitis

Start: 2013-01-31End: 2014-11-30Updated: 2015-03-27